CN Patent

CN216570857U — 改善药物物质适口性的剂型和多个剂型

Assigned to Acer Therapy · Expires 2022-05-24 · 4y expired

What this patent protects

本申请提供了改善药物物质适口性的剂型和多个剂型。所述剂型包括核心几何实体、与所述核心几何实体相连的药物几何实体以及包围所述药物几何实体的掩味几何实体。所述药物几何实体包括所述药物物质，并且当所述剂型口服施用于受试者时，所述掩味几何实体抑制所述药物物质从所述剂型快速释放。

USPTO Abstract

本申请提供了改善药物物质适口性的剂型和多个剂型。所述剂型包括核心几何实体、与所述核心几何实体相连的药物几何实体以及包围所述药物几何实体的掩味几何实体。所述药物几何实体包括所述药物物质，并且当所述剂型口服施用于受试者时，所述掩味几何实体抑制所述药物物质从所述剂型快速释放。

Drugs covered by this patent

Patent Metadata

Patent number
CN216570857U
Jurisdiction
CN
Classification
—
Expires
2022-05-24
Drug substance claim
No
Drug product claim
No
Assignee
Acer Therapy
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.